MONTI, M. Cutaneous Toxicity Induced By Cetuximab. American Society of Clinical Oncology. 2003, 21, 4651-4653
SALTZ, LB. Phase II atrial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor. Journal of Clinical Oncology. 2004, 22, 1201-1208